Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
7,585 Dovepress* 7,083+ 1,272 8,355
PubMed Central* 502 148 650
Totals 7,585 1,420 9,005
*Since 4 May 2018

View citations on PubMed Central and Google Scholar